Ozanimod

Quote






This product is going to be another S1P dog.... treatment is going the B cell therapy way. Ocrevus has more start forms weekly than any other therapy right now. We at Novartis enjoy the enthusiasm you guys have but get out of the way.....sub Cue B cell therapy right around the corner kids.......and you'll be begging for a form or two each month. P.S- There's about three more S1P's coming out plus a generic within the next year or two. Get the experience but expect a slow......slow......slow uptake and low.....low......low bonuses. Tah!
 






anonymous said:
This product is going to be another S1P dog.... treatment is going the B cell therapy way. Ocrevus has more start forms weekly than any other therapy right now. We at Novartis enjoy the enthusiasm you guys have but get out of the way.....sub Cue B cell therapy right around the corner kids.......and you'll be begging for a form or two each month. P.S- There's about three more S1P's coming out plus a generic within the next year or two. Get the experience but expect a slow......slow......slow uptake and low.....low......low bonuses. Tah!
Click to expand...


Agree 100%. Talked with my Neuros and many haven't even heard about the drug or cared about it. Turned down second interview....better opportunities out there.
 






I was told we will have a stacked ranking system, so I only need to beat the other dead beats, not any competitive products to maximize bonus. My docs already told me it will be a dog, but I want to make a bunch of money. I took the offer.
 












anonymous said:
You sound like a real “winner” lucky the company got you
Click to expand...


They got what they brought.... a slug of an eastern director who hired primary care managers to pretend he's the smartest one in the room, who hired their primary care reps from their previous companies be cause they were great 'sales people..... no thank you. I'll stay where I'm at. Sales force gets cut in half by years end......misery to follow.
 






anonymous said:
They got what they brought.... a slug of an eastern director who hired primary care managers to pretend he's the smartest one in the room, who hired their primary care reps from their previous companies be cause they were great 'sales people..... no thank you. I'll stay where I'm at. Sales force gets cut in half by years end......misery to follow.
Click to expand...
Agreed. Only the worst of the worst are clutching at straws to get this gig.
 






Sounds like sour grapes from those that aren’t getting interviews or offers. The reason they want specialty neurology reps without ms experience is for this reason-you’re a bunch of spoiled, overpaid prima-donnas. If you’ve seen 1 ms patient you’ve seen 1 ms patient so there needs to be many options. Talented sales reps will be able to position this product properly. After all, that’s why the industry needs us. If drugs sold themselves we’d be out of jobs.
 






anonymous said:
Sounds like sour grapes from those that aren’t getting interviews or offers. The reason they want specialty neurology reps without ms experience is for this reason-you’re a bunch of spoiled, overpaid prima-donnas. If you’ve seen 1 ms patient you’ve seen 1 ms patient so there needs to be many options. Talented sales reps will be able to position this product properly. After all, that’s why the industry needs us. If drugs sold themselves we’d be out of jobs.
Click to expand...
Many went elsewhere with better offers and better drugs, hardly sour grapes is it.
 


















anonymous said:
Sounds like sour grapes from those that aren’t getting interviews or offers. The reason they want specialty neurology reps without ms experience is for this reason-you’re a bunch of spoiled, overpaid prima-donnas. If you’ve seen 1 ms patient you’ve seen 1 ms patient so there needs to be many options. Talented sales reps will be able to position this product properly. After all, that’s why the industry needs us. If drugs sold themselves we’d be out of jobs.
Click to expand...

Position this properly???? Bahahahaha!!!! You're not positioning ANYTHING. It's a me too with a generic that will place you in a step edit with most plans. You'll get grouped in with the Gilenya opportunistic infection rates, PML and rebound effect after discontinuation. Go look them all up because it will take you about six months to dig yourself out of the hole you're primary care 'reach and frequency/ ask for the next three patient" sales model you understand got you into. After listening to the manager in my face to face interview I am well aware his inexperience of this space is NOT a good fit for those under him......too much Koolaid and not enough knowledge. Good luck.
 






















































Top Bottom
Back
Quote